ArticlePakistan journal of medical sciences2025
Evaluation of pharmacist's interventions in a Hospital Pharmacy of a Secondary Care Centre of Aga Khan University Hospital.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The current study aimed to investigate pharmacists' intervention statistics in a secondary care setting in Pakistan. Methodology: A retrospective cross-sectional study was conducted at a secondary care facility of Aga Khan University, Karachi, Pakistan, analyzing in-patient and out-patient pharmacy records from June 2022 to June 2023. Results: The study analyzed records of 10.9% (n=1340) male and female patients with a median age of six years (IQR: 23 years). Pharmacists intervened in 99.1% (n=1329) of prescriptions due to prescribing errors (PEs). The most common intervention was therapy optimization (e.g., therapeutic drug monitoring, incomplete prescriptions, wrong doses/frequencies, updating drug allergies, following culture/sensitivity results and monitoring electrolytes), accounting for 72.4% (n=970) of interventions, followed by route conversion at 19.6% (n=263). The overall acceptance rate of pharmacists' interventions among physicians was 88.7% (n=1189). Conclusion: PEs were common and pharmacists' interventions were vital in preventing patient harm. PEs were more frequent among in-patients at risk of polypharmacy. Pharmacists optimized therapy across all age groups by adjusting doses, administration routes and applying restrictions. The study noted high acceptance of these interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.